Taro Pharmaceutical (TARO) agrees to be taken private by India’s Sun Pharmaceutical Industries for $39.50/share, a 60% increase from a prior offer of $24.50. Sun had already owned 66% of Taro prior to the buyout, which is worth $571M.
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs